Recent NCCN guidelines Articles
Over the years I’ve coached many people who were determined to forego conventional cancer care—going against their oncologists’ recommendations, and often countering their partners’ and families’ opinions, too.
Professional cancer coaches can vary widely in terms of the type of support offered and their collective experience and expertise. I’ve created the following list, covering core attributes across vital areas of guidance, to consider when selecting an integrative, holistic cancer coach.
There is good news in the advancement of chemo-free approaches to managing chronic lymphocytic leukemia, and I am thrilled to share it with you. Results of the phase III ECOG trial found that the combination of ibrutinib (Imbruvica) plus rituximab (Rituxan) came out superior to the chemotherapy and immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.